심부전 POC 및 LOC 기기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 검사 유형별, 기술별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End Use, By Region & Competition, 2020-2030F
심부전 POC 및 LOC 기기 세계 시장 규모는 2024년 1억 1,024만 달러로 2030년까지 8.25%의 CAGR로 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다.
심부전 POC 및 LOC 기기 세계 시장은 심부전 환자를 위해 특별히 설계된 혁신적인 진단 및 모니터링 기기의 시장 개발 및 출시에 초점을 맞춘 헬스케어 산업에서 빠르게 발전하고 있는 분야입니다. 이러한 기기는 심부전 감지, 관리 및 치료를 위해 보다 효율적이고 비용 효율적이며 환자 친화적인 솔루션을 제공하는 것을 목표로 합니다. 또한, 특정 개발은 세계 심부전 LOC 및 POC 기기 시장의 성장으로 이어질 것입니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
1억 1,024만 달러 |
| 시장 규모 : 2030년 |
1억 7,597만 달러 |
| CAGR : 2025-2030년 |
8.25% |
| 급성장 부문 |
유전체 검사 |
| 최대 시장 |
북미 |
랩온칩(LOC) 기술은 신속하고 높은 처리량의 분석을 가능하게 하여 질병 진단에 있어 사용 편의성과 신뢰성을 향상시키고 있습니다. 특히 심부전 등 심혈관계 질환(CVD)에 대한 LOC 기반 분석에 대한 R&D 투자 확대가 시장 성장의 원동력이 되고 있으며, CVD는 전 세계 사망원인 1위로, 조기 발견과 효과적인 관리의 필요성이 높아지면서 진단에 대한 LOC 기술의 수요가 증가하고 있습니다. 진단에 대한 LOC 기술의 수요를 높이고 있습니다. 의료의 분산화와 개인화된 의료로의 전환은 보다 빠르고 쉽게 이용할 수 있는 진단 솔루션을 제공하는 현장진단(POC) 및 LOC 기기의 채택을 가속화하고 있습니다. 정부 기관은 자금 지원과 규제 승인을 통해 LOC 개발을 적극적으로 지원하고 있으며, 이를 통해 기술 혁신을 촉진하고 있습니다.
시장 촉진요인
심부전 유병률 증가
주요 시장 과제
정확성과 신뢰성
주요 시장 동향
인공지능(AI) 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 심부전 POC 및 LOC 기기 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 검사 유형별(단백질체 검사, 대사체 검사, 유전체 검사)
- 기술별(미세유체, 어레이 기반 시스템, 기타)
- 최종 용도별(병원, 외래 수술 센터, 재활 센터, 조사기관, 기타)
- 지역별
- 기업별(2024)
- 시장 맵
제6장 북미의 심부전 POC 및 LOC 기기 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 심부전 POC 및 LOC 기기 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 심부전 POC 및 LOC 기기 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 심부전 POC 및 LOC 기기 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 심부전 POC 및 LOC 기기 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
제11장 시장 역학
제12장 시장 동향과 발전
제13장 세계의 심부전 POC 및 LOC 기기 시장 : SWOT 분석
제14장 경쟁 구도
- Abbott Laboratories Inc
- Siemens Healthineers AG
- Danaher Corp
- Instrumentation Laboratory Co
- F Hoffmann-La Roche AG
- bioMerieux S.A.
- Abaxis Inc
- Quidel Corp
- Jant Pharmacal Corp
- Trinity Biotech plc
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
Global Heart Failure POC And LOC Devices Market was valued at USD 110.24 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.25% through 2030. The Global Heart Failure POC and LOC Devices Market refers to a rapidly evolving sector within the healthcare industry that focuses on the development and deployment of innovative diagnostic and monitoring devices specifically designed for heart failure patients. These devices aim to provide more efficient, cost-effective, and patient-friendly solutions for the detection, management, and treatment of heart failure. Also, certain development also leads to the growth of global heart failure LOC and POC devices market.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 110.24 Million |
| Market Size 2030 | USD 175.97 Million |
| CAGR 2025-2030 | 8.25% |
| Fastest Growing Segment | Genomic testing |
| Largest Market | North America |
Lab-on-a-Chip (LOC) technology enables rapid, high-throughput analyses, improving ease of use and reliability in disease diagnosis. Growing R&D investments in LOC-based assays, particularly for cardiovascular diseases (CVD) such as heart failure, are driving market growth. With CVD being a leading cause of mortality worldwide, the increasing need for early detection and effective management is boosting demand for LOC technology in diagnostics. The shift towards decentralized healthcare and personalized medicine is accelerating the adoption of point-of-care (POC) and LOC devices, offering faster, more accessible diagnostic solutions. Government bodies are actively supporting LOC development through funding initiatives and regulatory approvals, encouraging further innovation.
Key Market Drivers
Rising Prevalence of Heart Failure
Heart failure is a pervasive and chronic cardiovascular condition, affecting millions of people worldwide. With an aging population, sedentary lifestyles, and an increasing prevalence of risk factors such as obesity and diabetes, the incidence of heart failure is on the rise. However, this health crisis has given rise to an opportunity for innovation in healthcare. The Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is experiencing remarkable growth due to the escalating prevalence of heart failure.
Diabetes is a global health crisis, placing a substantial burden on developing countries like India, which is often referred to as the diabetes capital of the world. According to the ICMR-INDIAB study, over 101 million people in India are living with diabetes. The disease is linked to high morbidity and mortality, with nearly 46% of diabetic patients developing cardiovascular disease (CVD) during their lifetime. CVD is a leading cause of death among Type 2 diabetes (T2D) patients, accounting for nearly 50% of diabetes-related fatalities. Approximately 30% of diabetic patients develop heart failure, and those with both T2D and heart failure face an eightfold higher risk of death compared to individuals without heart failure. These alarming statistics highlight the urgent need for early diagnosis, intervention, and innovative treatment strategies to reduce the impact of diabetes-related cardiovascular complications.
Key Market Challenges
Accuracy and Reliability
POC and LOC devices need to be highly accurate and reliable, as errors can lead to misdiagnoses or improper management of heart failure. Ensuring consistent accuracy remains a significant challenge, especially for smaller and portable devices.
Key Market Trends
Integration of Artificial Intelligence (AI)
Artificial intelligence is increasingly being incorporated into POC and LOC devices. AI can enhance diagnostic accuracy, personalize treatment plans, and provide predictive analytics to identify potential heart failure exacerbations before they occur.
Key Market Players
- Abbott Laboratories Inc
- Siemens Healthineers AG
- Danaher Corp
- Instrumentation Laboratory Co
- F Hoffmann-La Roche AG
- bioMerieux S.A.
- Abaxis Inc
- Quidel Corp
- Jant Pharmacal Corp
- Trinity Biotech plc
Report Scope:
In this report, the Global Heart Failure POC And LOC Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Heart Failure POC And LOC Devices Market, By Test Type:
- Proteomic testing
- Metabolomic testing
- Genomic testing
Heart Failure POC And LOC Devices Market, By Technology:
- Microfluidics
- Array-based systems
- Others
Heart Failure POC And LOC Devices Market, By End Use:
- Clinics
- Hospitals
- Home
- Assisted living healthcare facilities
- Laboratory
- Others
Heart Failure POC And LOC Devices Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Heart Failure POC And LOC Devices Market.
Available Customizations:
Global Heart Failure POC And LOC Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Source
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Heart Failure POC And LOC Devices Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Test Type (Proteomic testing, Metabolomic testing, Genomic testing)
- 5.2.2. By Technology (Microfluidics, Array-based systems, Others)
- 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Rehabilitation Centers, Research Institutes, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
- 5.3. Market Map
6. North America Heart Failure POC And LOC Devices Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Technology
- 6.2.3. By End User
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Heart Failure POC And LOC Devices Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Technology
- 6.3.1.2.3. By End User
- 6.3.2. Canada Heart Failure POC And LOC Devices Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Technology
- 6.3.2.2.3. By End User
- 6.3.3. Mexico Heart Failure POC And LOC Devices Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Technology
- 6.3.3.2.3. By End User
7. Europe Heart Failure POC And LOC Devices Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Technology
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Heart Failure POC And LOC Devices Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Technology
- 7.3.1.2.3. By End User
- 7.3.2. United Kingdom Heart Failure POC And LOC Devices Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Technology
- 7.3.2.2.3. By End User
- 7.3.3. Italy Heart Failure POC And LOC Devices Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Technology
- 7.3.3.2.3. By End User
- 7.3.4. France Heart Failure POC And LOC Devices Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Technology
- 7.3.4.2.3. By End User
- 7.3.5. Spain Heart Failure POC And LOC Devices Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Technology
- 7.3.5.2.3. By End User
8. Asia-Pacific Heart Failure POC And LOC Devices Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Technology
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Heart Failure POC And LOC Devices Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Technology
- 8.3.1.2.3. By End User
- 8.3.2. India Heart Failure POC And LOC Devices Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Technology
- 8.3.2.2.3. By End User
- 8.3.3. Japan Heart Failure POC And LOC Devices Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Technology
- 8.3.3.2.3. By End User
- 8.3.4. South Korea Heart Failure POC And LOC Devices Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Technology
- 8.3.4.2.3. By End User
- 8.3.5. Australia Heart Failure POC And LOC Devices Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Technology
- 8.3.5.2.3. By End User
9. South America Heart Failure POC And LOC Devices Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Technology
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Heart Failure POC And LOC Devices Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Technology
- 9.3.1.2.3. By End User
- 9.3.2. Argentina Heart Failure POC And LOC Devices Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Technology
- 9.3.2.2.3. By End User
- 9.3.3. Colombia Heart Failure POC And LOC Devices Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Technology
- 9.3.3.2.3. By End User
10. Middle East and Africa Heart Failure POC And LOC Devices Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Technology
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Heart Failure POC And LOC Devices Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Technology
- 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Heart Failure POC And LOC Devices Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Technology
- 10.3.2.2.3. By End User
- 10.3.3. UAE Heart Failure POC And LOC Devices Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Technology
- 10.3.3.2.3. By End User
- 10.3.4. Kuwait Heart Failure POC And LOC Devices Market Outlook
- 10.3.4.1. Market Size & Forecast
- 10.3.4.2. Market Share & Forecast
- 10.3.4.2.1. By Type
- 10.3.4.2.2. By Technology
- 10.3.4.2.3. By End User
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Developments
- 12.2. Product Launches
- 12.3. Mergers & Acquisitions
13. Global Heart Failure POC And LOC Devices Market: SWOT Analysis
14. Competitive Landscape
- 14.1. Abbott Laboratories Inc
- 14.1.1. Business Overview
- 14.1.2. Technology Offerings
- 14.1.3. Recent Developments
- 14.1.4. Key Personnel
- 14.1.5. SWOT Analysis
- 14.2. Siemens Healthineers AG
- 14.3. Danaher Corp
- 14.4. Instrumentation Laboratory Co
- 14.5. F Hoffmann-La Roche AG
- 14.6. bioMerieux S.A.
- 14.7. Abaxis Inc
- 14.8. Quidel Corp
- 14.9. Jant Pharmacal Corp
- 14.10.Trinity Biotech plc
15. Strategic Recommendations
16.About Us & Disclaimer
